Search USP29

USP29

281 General Chapters: <1046> CELL AND GENE THERAPY PRODUCTS - REGULATIONS, STANDARDS, AND NEW METHODOLOGIES

282 General Chapters: <1046> CELL AND GENE THERAPY PRODUCTS - DEFINITION OF TERMS

283 General Chapters: <1046> CELL AND GENE THERAPY PRODUCTS - ABBREVIATIONS

284 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS

285 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS(1)

286 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS - AMINO ACID ANALYSIS

287 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS - PEPTIDE MAPPING

288 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS - POLYACRYLAMIDE GEL ELECTROPHORESIS

289 General Chapters: <1047> BIOTECHNOLOGY-DERIVED ARTICLES-TESTS - TOTAL PROTEIN ASSAY

290 General Chapters: <1048> QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r-DNA DERIVED PROTEIN PRODUCTS

291 General Chapters: <1049> QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS

292 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN

293 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN(1)

294 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - I. INTRODUCTION

295 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - II. POTENTIAL SOURCES OF VIRUS CONTAMINATION

296 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - III. CELL LINE QUALIFICATION: TESTING FOR VIRUSES

297 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - IV. TESTING FOR VIRUSES IN UNPROCESSED BULK

298 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - V. RATIONALE AND ACTION PLAN FOR VIRAL CLEARANCE STUDIES AND VIRUS TESTS ON PURIFIED BULK

299 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - VI. EVALUATION AND CHARACTERIZATION OF VIRAL CLEARANCE PROCEDURES

300 General Chapters: <1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN - VII. SUMMARY

(Total 232 pages) 10 11 12 13 14 15 16 17 18 19 20

Copyright © 2008-2010 Pharmacopeia.cn USP31 E-mail:webmaster#pharmacopeia.cn (Please replace # with @ to send a e-mail)